Mark Feinberg
Director, Program in Cardiovascular RNA Biology Research · Brigham and Women's Hospital
Credentials: · · · ·
History
- Present
Program in Cardiovascular RNA Biology Research · Brigham and Women's Hospital
- Present
- Present
1998–2001- 1994–1996
Duke University Medical Center-GME
- 1990–1994
MED COLL OF PENNSYLVANIA, PHILADELPHIA
Research
KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation
The Journal of Experimental Medicine · 2004 · 597 citations
MicroRNA Regulation of Atherosclerosis
Review · Circulation Research · 2016 · First of 2 authors · Corresponding · 515 citations
MicroRNA-181b regulates NF-κB-mediated vascular inflammation
Journal of Clinical Investigation · 2012 · Last of 12 authors · 440 citations
17 papers · 4 as a fellow
12 papers
- WW
10 papers · 10 as a resident
9 papers
- MS
9 papers
9 papers
7 papers · 2 as a resident
7 papers
Grants
- 2026–2033
Non-Coding RNAs and Chronic Limb Threatening Ischemia
National Heart, Lung, and Blood Institute · R35
Contact PI · $1.2M · Brigham and Women's Hospital
- 1985–2030
Training Grant in Cardiovascular Research
National Heart, Lung, and Blood Institute · T32
Contact PI · $1.8M · Brigham and Women's Hospital
- 2024–2028
LncRNA MERRICAL, Macrophage Chemotaxis, and Diabetes-Associated Atherosclerosis
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.3M · Brigham and Women's Hospital
- 2023–2027
miR-130b, Angiogenesis, and Diabetic Critical Limb Ischemia
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.3M · Brigham and Women's Hospital